Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.

Abstract The identification and evolution of a series of potent and selective p38 inhibitors is described. p38 inhibitors based on a N -benzyl pyridinone high-throughput screening hit were prepared and their SAR explored. Their design was guided by ligand bound co-crystals of p38α. These efforts resulted in the identification of 12r and 19 as orally active inhibitors of p38 with significant efficacy in both acute and chronic models of inflammation.